# Gechun Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/gechun-biotechnology

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Website: www.greenpurity.cn
- Total disclosed funding: $14M
- Latest round: Series A (Nov 23, 2023)
- Investors on record: 2

## About

Founded in 2017 and based in Chengdu, China, Gechun Biotechnology operates as a pharmaceutical intermediate industrialization platform, focusing on biopharmaceutical R&D services. It was honored as a National High-Tech Enterprise. The company has a subsidiary named LESHAN LIYUAN TECHNOLOGY. There are three R&D centers and one production base in Chengdu, Leshan and Yanting. Gechun Biotechnology has established cooperative relationships with institutions, enterprises and scientific research units such as Sichuan University, Tianjin University of Science and Technology, U.S. Pharmacopoeia Commission, Sigma, Shanghai Yuanye Biological. In November 2023, it raised series A funding.

Gechun Biotechnology is mainly engaged in the research and development of APIs, pharmaceutical intermediates, cosmetic raw materials and food additives. It also conducts research on Chinese herbal medicines and preclinical research on innovative natural medicines. The company established a library of compounds, providing natural product intermediates, Chinese medicine chemical components, and natural product extractions for the Chinese medicine industry. It also provides services such as compound isolation and purification, compound modification, and compound activity screening and testing.

The company will use the funding for R&D and innovation of cosmetic active ingredients.

## Funding rounds

- Series A, Nov 23, 2023, $14M — YuanBio Venture, Sichuan Venture Capital

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A
- Sichuan Venture Capital (https://capitalatlas.ai/funds/sichuan-venture-capital) — Series A